The most important number in Lake Forest Regenesis’s published pricing is also the easiest to misread. Its $119-per-month membership pays for direct primary care, not its medical weight-loss program. Medications, laboratory work and specialty programs are separate from that membership. For an adult comparing GLP-1 options, the distinction matters more than the headline amount: the consulted pages do not establish the cost of entering weight-management care, receiving medication or continuing treatment.
Lake Forest Regenesis is an in-person clinic in Lake Forest, Illinois, advertising semaglutide- or tirzepatide-based treatment when clinically appropriate. Its documented process includes two 90-minute appointments, laboratory testing and ongoing monitoring. This review examines what those services could mean for a self-pay budget without inventing a package price. The official sources, consulted October 19, 2026, provide a clearer account of the clinical pathway than of its billing structure, leaving several financial questions to resolve before booking.
At a glance
- Published price belongs to primary care
- The $119/month Direct Primary Care membership excludes medications, labs, imaging and specialty programs such as medical weight loss.Sources: [3]
- Self-pay services
- Lake Forest Regenesis says it does not bill insurance and explains payment options when patients book.Sources: [8]
- Two-stage evaluation
- The GLP-1 pathway describes a 90-minute initial consultation with blood collection, followed by a 90-minute results-review appointment.Sources: [5]
- Conditional medication options
- The clinic advertises semaglutide- or tirzepatide-based therapy when clinically appropriate, alongside evaluation, lifestyle guidance and monitoring.Sources: [5]
Start by separating the $119 membership from weight-loss care
Lake Forest Regenesis describes its $119/month Direct Primary Care membership as an ongoing primary-care relationship with Allana Bush, FNP-C. Covered services include sick visits, preventive care, physicals and continuing health concerns. The same description explicitly separates medications, labs, imaging, medical weight loss and hormone therapy from membership coverage. Consequently, $119 is neither a documented GLP-1 starting price nor evidence that an additional $119 membership is required to access weight-management treatment.
That separation also applies to support. Primary-care members are offered contact with Allana by email, text, portal message or phone, with a response within one business day. The supplied sources do not establish that this response commitment extends to a stand-alone GLP-1 patient. Someone comparing programs should avoid assigning financial value to that access until the clinic confirms which communication services accompany the weight-loss fee.
The useful comparison is therefore not this membership against another clinic’s medication-inclusive price. It is a written GLP-1 quote against another quote with equivalent components. Our guide to what a GLP-1 program price includes explains that distinction. At Lake Forest Regenesis, the first task is to establish whether evaluation, testing, prescribing, medication and follow-up are separately charged or combined, rather than assuming the primary-care membership supplies the missing price.
| Item | Documented position | Question before payment |
|---|---|---|
| Direct Primary Care | $119 per month for primary-care membership | Is membership optional for weight-loss patients? |
| Initial GLP-1 evaluation | 90-minute consultation with blood collection | What are the visit and laboratory charges? |
| Results review | Second 90-minute appointment | Is this included in an evaluation fee? |
| Medication | Semaglutide or tirzepatide when appropriate | What exact product, quantity and price are quoted? |
| Ongoing care | Monitoring and provider oversight described | What follow-up and medication charges recur, and when? |
The first payment needs its own written explanation
The clinic’s GLP-1 process starts with a 90-minute consultation with Allana covering health history, current medicines, previous weight-loss efforts, symptoms and personal goals. Blood is drawn during that visit. After results return, a second 90-minute appointment reviews the laboratory and health information to determine whether GLP-1-based treatment may be appropriate. These are documented steps in evaluation, not a promise that medication will be prescribed or that both visits share one charge.
For budgeting, the critical unknown is how much becomes payable before that clinical decision. The supplied pages do not price either appointment, identify the laboratory charges or explain whether an evaluation fee includes both visits. They also do not say what a patient owes if medication is not recommended. Asking for this scenario explicitly is more useful than asking only for a monthly medication price: the evaluation may lead to a different plan or no GLP-1 prescription.
Request an itemized estimate that separates the amount due at booking, at the first visit, for testing and after the results review. The sources do not establish deposits, prepayment requirements or an introductory discount, so none should be assumed. The distinction between an entry charge and continuing expenses is explored in understanding the first GLP-1 payment. Here, the two-appointment pathway makes that distinction especially important, even before medication costs enter the calculation.
Self-pay is clear; payment timing and commitments are not
The terms identify the business as Lake Forest Regenesis Medical Center PLLC and state that it does not bill insurance. Services are self-pay, with payment options explained when booking. That establishes the clinic’s billing approach, but it does not establish an all-inclusive cash package or explain how a dispensing pharmacy might charge. Nor does it determine whether an individual insurance plan might cover a particular medicine through another arrangement; coverage requires separate confirmation.
The terms also say website prices and programs may change without notice. Third-party financing, including payment plans offered by outside providers, is subject to that provider’s terms and approval. This language is not a specific financing offer or evidence that a patient qualifies. Before accepting any arrangement, ask for the actual payment schedule and distinguish the clinic’s charges from any outside financing obligations rather than treating installments as a reduction in treatment cost.
No GLP-1 renewal interval, minimum commitment, automatic-renewal provision, cancellation deadline or refund policy was identified in the supplied material. That absence is not proof of flexible cancellation or refundable payments. It means these terms need documentation before money changes hands. A clinical decision to stop medication also should not be assumed to end a financial arrangement. For the broader distinction between clinic billing and benefit coverage, see insurance and self-pay questions.
Identify the medication before comparing its price
Lake Forest Regenesis advertises semaglutide- or tirzepatide-based therapy when clinically appropriate. Its individual medication pages describe the usual route as an injection under the skin. However, these descriptions do not identify the exact product a particular patient would receive, its presentation or its supplied quantity. References to familiar brands in educational comparisons are not confirmation that those brands are dispensed. A meaningful quote should name the prescribed product rather than rely on an ingredient alone.
Both medication pages address compounded treatment conditionally: when compounded semaglutide or tirzepatide is prescribed, the clinic says an FDA-registered compounding pharmacy prepares it. The pages also acknowledge that compounded medications are not FDA approved. Elsewhere, the clinic says it obtains medicines from compounding or specialty pharmacies selected for quality and dosing accuracy. Those are provider statements; the supplied evidence does not identify the pharmacies or independently verify their registrations or selection standards.
FDA explains that compounded drugs do not undergo its premarket review for safety, effectiveness and quality, and recommends them when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence, and pharmacy registration is not product approval. Ask which pharmacy will dispense, whether the preparation is compounded, what quantity is supplied and whether the pharmacy sends a separate bill.
Ongoing monitoring belongs in the recurring budget
The advertised program extends beyond an initial prescription. Follow-up is described as reviewing weight progress, appetite changes, medication tolerance, side effects and overall health, with treatment adjustments when needed. Nutritional and lifestyle guidance accompanies medical oversight. These are substantive service descriptions, but they do not establish the price, frequency or format of later appointments, or whether additional tests and communications are included. A recurring quote needs to connect each charge to the actual service provided.
Treatment length is individualized according to progress, tolerance, health needs and long-term goals. The clinic says a plan may be adjusted, paused or discontinued because of response, changing needs or clinical concerns. It also describes possible transition to long-term maintenance, with some patients continuing medication and others changing treatment. None of those clinical descriptions establishes a prepaid package duration, minimum financial commitment or fixed number of medication supplies.
Ask how billing changes during a pause, after a medication change and during maintenance. Those are foreseeable branches of the clinic’s own pathway, not reasons to assume any particular outcome. NIDDK describes obesity as a chronic disease that may require long-term care and notes that treatment duration depends on response and side effects. The practical budgeting implication is to obtain continuing-care prices without assuming either a short course or indefinite use.
In-person care adds practical costs and scheduling questions
The clinic markets its GLP-1 services to men and women in Lake Forest, Chicago’s North Shore and Lake County. Its terms say all services are provided in person after an appropriate medical evaluation. The listed office is 1025 W. Everett Road, Suite 2, in the same building as Lake Forest Acute Care Center, at Everett and Waukegan roads. Suite 2 is on the lower level and can be reached by stairs or elevator.
Published hours are 8 a.m. to 6 p.m. Monday through Wednesday and Friday, plus 9 a.m. to 1 p.m. Saturday; Thursday and Sunday are closed. Those hours help with planning but do not guarantee an available appointment. Two 90-minute evaluation visits mean that travel and time away from work may matter alongside direct charges. No laboratory turnaround, prescribing-decision deadline or treatment-start timeline was established in the supplied pages.
Medication logistics remain less defined than the office location. The evidence does not explain pickup versus shipping, delivery charges, cold-chain arrangements or dispatch and arrival timing. Ask who handles a delayed or compromised supply and whether any replacement charge applies. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. That guidance is general context, not evidence of a delivery problem at this clinic.
What the evaluation promises—and what it does not
The clinic identifies Allana Bush, FNP-C, as its lead medical provider and attributes more than 20 years of healthcare experience to her. FNP-C denotes a family nurse practitioner credential, not a physician designation; these credentials and experience were not independently verified for this review. The described GLP-1 audience is adults who have struggled to lose or maintain weight through nutrition and exercise alone or who have weight-related health concerns.
Its pages expect candidates to participate in ongoing follow-up, lifestyle changes and long-term weight management. The general GLP-1 page says treatment may not be recommended during breastfeeding or with certain medical histories, contraindications, medication interactions or other clinical concerns. The individual semaglutide and tirzepatide pages state that these medicines are not used during pregnancy or in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2). The tirzepatide page also calls for careful review of a history of pancreatitis, gallbladder disease or kidney problems. It also warns that oral birth control may be less effective for about four weeks after starting tirzepatide and after each dose increase; patients should discuss this interaction with their clinician. These are the provider’s stated screening boundaries, not an individualized eligibility determination. The supplied evidence does not publish numerical BMI criteria or establish that completing or paying for the evaluation guarantees a prescription.
The clinic also states that no specific amount or speed of weight loss can be guaranteed. That matters when assessing value: consultation length and medication access do not establish an individual result. Emsculpt NEO is separately described as a possible body-composition complement, not an obesity or weight-loss treatment and not a replacement for medical weight management. It should not be assumed necessary, included or equivalent to the GLP-1 program when reviewing a proposed bill.
Use the booking conversation to obtain a complete quote
No referral is required, and the clinic says patients can schedule directly. Its published contact routes include 224-436-8006 and info@lakeforestregenesis.com. A website booking request is not itself a confirmed appointment: the terms say confirmation occurs when the office contacts the patient to confirm the date and time. Use that exchange to request financial details, including any appointment-cancellation charge, before treating the reservation as a settled plan.
The most useful request is a written breakdown for the initial evaluation and the expected continuing arrangement, with the medicine identified separately. Include laboratory charges, follow-up frequency, supplies, pharmacy billing and any delivery fee. Ask what is payable if treatment is not recommended, if a medicine is unavailable or if the clinician pauses treatment. Our prepayment question checklist can help organize that conversation without assuming this clinic uses a subscription model.
A complete response should also identify the billing interval and any renewal, cancellation and refund terms. The supplied evidence supports neither a monthly GLP-1 fee nor a four-week schedule, and it establishes no required prepayment. Without those answers, comparing Lake Forest Regenesis on affordability would be premature. With them, a prospective patient could assess the documented two-visit evaluation and local follow-up against the actual out-of-pocket obligation rather than the unrelated primary-care headline.
Questions & answers
Does Lake Forest Regenesis offer GLP-1 treatment for $119 a month?
The documented $119 monthly price is for Direct Primary Care, not GLP-1 care. The clinic explicitly separates medical weight loss, medications and laboratory services from that membership. The supplied pages do not establish a GLP-1 program price or say that joining primary care is required for weight-loss treatment.
What happens before a medication decision?
The described pathway includes a 90-minute visit with Allana to review history, medicines, prior weight-loss efforts and goals, with blood drawn then. A second 90-minute visit reviews results and suitability for GLP-1-based therapy. The pages do not establish either appointment’s price, laboratory turnaround or a guaranteed prescription.
Will the clinic bill my insurance?
Its terms say no: services are self-pay, and payment options are explained when booking. That statement does not settle an individual medicine’s insurance coverage or identify a pharmacy’s billing arrangement. Ask the clinic and prospective dispensing pharmacy separately, and confirm any potential coverage directly with your plan.
Does the clinic identify which pharmacy supplies medication?
Not in the supplied passages. It says medicines come from compounding or specialty pharmacies and conditionally describes compounded semaglutide and tirzepatide as prepared by an FDA-registered compounding pharmacy. Ask for the pharmacy’s name, the exact prescribed preparation and the billing process. Registration is not FDA approval of a compounded medication.
Can I receive this service entirely online?
The consulted terms describe all services as in person, and the office is in Lake Forest, Illinois. They do not establish an interstate telehealth program. You can request an appointment directly without a referral, but an online request only becomes confirmed when the office contacts you with the date and time.
What happens financially if treatment is paused or stopped?
The clinic says clinical plans can be adjusted, paused or discontinued, but the supplied material does not establish the associated financial rules. Ask whether charges continue, which services remain available and whether unused payments are refundable. A clinical pause is not evidence of a billing pause, and cancellation should not be assumed to produce a refund.
Our assessment
Lake Forest Regenesis documents a local, in-person GLP-1 pathway with substantial evaluation time, laboratory review and continuing oversight. Those details give prospective patients concrete services to ask about, rather than just a medication advertisement. Its cost transparency is less complete: the supplied pages do not establish evaluation charges, medication prices, recurring totals or exit terms. The $119 primary-care membership cannot fill those gaps. The balanced conclusion is that the clinic merits a quote-based comparison, not a low-price designation. Before paying, obtain an itemized estimate covering both evaluation visits, testing, the exact medication and pharmacy, follow-up and cancellation or refund boundaries. Only then can the described care model be weighed against a clear financial commitment.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Lake Forest Regenesis — official website ↗
- Lake Forest Regenesis — medical weight loss ↗
- Lake Forest Regenesis — medical weight loss/glp 1 therapy ↗
- Lake Forest Regenesis — contact ↗
- Lake Forest Regenesis — medical weight loss/semaglutide ↗
- Lake Forest Regenesis — terms ↗
- Lake Forest Regenesis — medical weight loss/tirzepatide ↗
- Lake Forest Regenesis — about ↗